(Q36885939)

16 August 2017

1 reference

title

MR angiography with blood pool contrast agents (English)

1 reference

16 August 2017

1 reference

1 reference

Jens Bremerich

0 references

Deniz Bilecen

1 reference

16 August 2017

Peter Reimer

series ordinal

1 reference

16 August 2017

language of work or name

English

0 references

publication date

17 July 2007

1 reference

16 August 2017

1 reference

16 August 2017

1 reference

16 August 2017

1 reference

16 August 2017

page(s)

3017-3024

1 reference

Expanding role of MR angiography in clinical practice.

16 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00330-007-0712-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-007-0712-0

Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00330-007-0712-0

Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores

21 January 2018

1 reference

12 December 2020

Contrast-enhanced blood-pool MR angiography with optimized iron oxides: effect of size and dose on vascular contrast enhancement in rabbits

1 reference

12 December 2020

Development of new glucosylated derivatives of gadolinium diethylenetriaminepentaacetic for magnetic resonance angiography.

1 reference

12 December 2020

Rationale and applications for macromolecular Gd-based contrast agents

1 reference

12 December 2020

Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool and perfusion imaging

1 reference

12 December 2020

Contrast agent-enhanced, free-breathing, three-dimensional coronary magnetic resonance angiography

1 reference

12 December 2020

MR image-guided endovascular procedures with the ultrasmall superparamagnetic iron oxide SH U 555 C as an intravascular contrast agent: study in pigs

1 reference

12 December 2020

MR coronary angiography with SH L 643 A: initial experience in patients with coronary artery disease

1 reference

12 December 2020

High-spatial-resolution multistation MR angiography with parallel imaging and blood pool contrast agent: initial experience.

1 reference

12 December 2020

Phase I clinical evaluation of citrate-coated monocrystalline very small superparamagnetic iron oxide particles as a new contrast medium for magnetic resonance imaging

1 reference

12 December 2020

Functional tumor imaging with dynamic contrast‐enhanced magnetic resonance imaging

1 reference

12 December 2020

Comparison of the iron oxide-based blood-pool contrast medium VSOP-C184 with gadopentetate dimeglumine for first-pass magnetic resonance angiography of the aorta and renal arteries in pigs

1 reference

12 December 2020

A preliminary report comparing magnetic resonance coronary angiography with conventional angiography

1 reference

12 December 2020

Critical limb ischemia: hybrid MR angiography compared with DSA.

1 reference

12 December 2020

Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization

1 reference

12 December 2020

Assessment of gadobenate dimeglumine for magnetic resonance angiography: phase I studies.

1 reference

12 December 2020

Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths

1 reference

12 December 2020

Carotid MR angiography: phase II study of safety and efficacy for MS-325

1 reference

12 December 2020

Pharmacokinetics of Gadomer-17, a new dendritic magnetic resonance contrast agent

1 reference

12 December 2020

Three-dimensional MR imaging of pulmonary vessels and parenchyma with NC100150 injection (Clariscan).

1 reference

12 December 2020

Prospective blinded evaluation of Gd-DOTA- versus Gd-BOPTA-enhanced peripheral MR angiography, as compared with digital subtraction angiography

1 reference

12 December 2020

AUR Memorial Award 1991. Immunogenicity of gadolinium-based contrast agents for magnetic resonance imaging. Induction and characterization of antibodies in animals

1 reference

12 December 2020

Utilizing SENSE to reduce scan duration in high-resolution contrast-enhanced renal MR angiography

1 reference

12 December 2020

Nephrogenic systemic fibrosis: A serious late adverse reaction to gadodiamide

1 reference

12 December 2020

MR Angiography with Gadofosveset Trisodium for Peripheral Vascular Disease: Phase II Trial

1 reference

12 December 2020

Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis

1 reference

12 December 2020

Effect of field strengths on magnetic resonance angiography: comparison of an ultrasmall superparamagnetic iron oxide blood-pool contrast agent and gadopentetate dimeglumine in rabbits at 1.5 and 3.0 tesla

1 reference

12 December 2020

Coronary arteries: contrast-enhanced MR imaging with SH L 643A--experience in 12 volunteers

1 reference

12 December 2020

MS-325: albumin-targeted contrast agent for MR angiography

1 reference

12 December 2020

A summary of safety of gadofosveset (MS-325) at 0.03 mmol/kg body weight dose: Phase II and Phase III clinical trials data

1 reference

12 December 2020

Macromolecular contrast medium (feruglose) versus small molecular contrast medium (gadopentetate) enhanced magnetic resonance imaging: differentiation of benign and malignant breast lesions

1 reference

12 December 2020

First-pass and equilibrium phase MRA following intravenous bolus injection of SH U 555 C: Phase I clinical trial in elderly volunteers with risk factors for arterial vascular disease

1 reference

12 December 2020

First-pass and equilibrium-MRA of the aortoiliac region with a superparamagnetic iron oxide blood pool MR contrast agent (SH U 555 C): results of a human pilot study

1 reference

12 December 2020

Cuff-compression of the proximal calf to reduce venous contamination in contrast-enhanced stepping-table magnetic Resonance angiography

1 reference

12 December 2020

Three-dimensional MR pulmonary perfusion imaging and angiography with an injection of a new blood pool contrast agent B-22956/1

1 reference

12 December 2020

Myocardial perfusion and MR angiography of chest with SH U 555 C: results of placebo-controlled clinical phase i study

1 reference

12 December 2020

Magnetic iron oxide particles coated with carboxydextran for parenteral administration and liver contrasting. Pre-clinical profile of SH U555A.

1 reference

12 December 2020

Comparison of two blood pool contrast agents for 0.5-T MR angiography: experimental study in rabbits

1 reference

12 December 2020

High-spatial-resolution MR angiography of renal arteries with integrated parallel acquisitions: comparison with digital subtraction angiography and US.

1 reference

12 December 2020

Nephrogenic systemic fibrosis: risk factors and incidence estimation.

1 reference

12 December 2020

10.1007/S00330-007-0712-0

Identifiers

DOI

1 reference

16 August 2017

1 reference